about
Systematic Review of Pharmacological Properties of the Oligodendrocyte LineageMicroglia and mast cells: two tracks on the road to neuroinflammationA proteomic approach in the study of an animal model of Parkinson's disease.A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor CellsLigand engagement of Toll-like receptors regulates their expression in cortical microglia and astrocytesReference Values for a Panel of Cytokinergic and Regulatory Lymphocyte Subpopulations.The P2X7 purinergic receptor: from physiology to neurological disorders.Toll-like receptors 2, -3 and -4 prime microglia but not astrocytes across central nervous system regions for ATP-dependent interleukin-1β release.Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.Mast cells, glia and neuroinflammation: partners in crime?Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3.Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.Synaptic Plasticity, Dementia and Alzheimer Disease.Physiological and pharmacological bases for the diverse properties of benzodiazepines and their congeners.Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A.Lack of anticonvulsant tolerance and benzodiazepine receptor down regulation with imidazenil in rats.Analgesic properties of N-terminal substituted phenylalanyl-alanine.Characterization of [3H]-imidazenil binding to rat brain membranesSynthesis and quantitative structure-activity relationships of analeptic agents related to dimefline.Photoisomerization of fluvoxamine generates an isomer that has reduced activity on the 5-hydroxytryptamine transporter and does not affect cell proliferation.Consumption of opioid analgesics in italy: light at the end of the tunnel?Antidepressant drug prescribing patterns to outpatients of an Italian local health authority during the years 1998 to 2008.An experimental study on dependence liability of zipeprol.Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities.Effects of the neurotoxin MPTP and pargyline protection on extracellular energy metabolites and dopamine levels in the striatum of freely moving rats.Benefit of statins in daily practice? A six-year retrospective observational study.1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity.Active Induction of Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice.Molecular network-selected pharmacogenomics in a case of bipolar spectrum disorder.Real-practice thromboprophylaxis in atrial fibrillation.Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons.Co-Ultramicronized Palmitoylethanolamide/Luteolin Facilitates the Development of Differentiating and Undifferentiated Rat Oligodendrocyte Progenitor Cells.Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?Abecarnil enhances recovery from diazepam tolerance.Effect of acute and chronic tramadol on [3H]-norepinephrine-uptake in rat cortical synaptosomes.Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique.
P50
Q26768210-AE8D2F2E-E503-4A80-BBA4-F8751359AACEQ26865144-A6E60C6F-9FAD-4432-A825-8977F73C6C93Q33216776-42048E82-A5DE-443C-AAE0-A5C02FF63C3AQ35406578-005D6C7A-67F3-4588-834D-F3C8F734A17DQ36290946-CC6B0991-CE62-4311-9C7D-C71155C6BF5CQ36416913-5C677320-4B36-42B7-A58F-941508886BEFQ37541443-B484670E-BD5D-4408-B43C-0B0E44342305Q37610687-42168C3F-A1AA-4039-A298-7680D4B88518Q37738372-B7C237D2-4EA4-4749-9188-CC350E8BF7C0Q38118187-0FEF5957-3317-4465-8D05-C04FC995E7B4Q38137173-05C118CF-8BB2-4BCB-9907-1412CD171DFDQ38157791-464FF347-2E92-49EC-AEAB-C3547C00F54FQ38214996-B03DA19B-6FDD-48A2-92FB-3AB4FBB181BAQ38367771-01DC959C-6C0D-4FAB-9501-CE7ABC66CEB9Q38521270-D1511021-2DB7-4215-B427-BAD2AEB71300Q39020059-E84FD452-7F86-454D-BE5C-6C18526B00D6Q40855865-3E90F799-AA0F-40D3-B880-EBC53C9E3419Q42030450-89EF1E61-EBDF-4927-92DA-67ABB6A8CC05Q42165508-273A3787-7731-463D-988B-F23022F86CBCQ42247558-817B1619-24AB-4259-B384-B3F01109140FQ42370041-66FA4140-8491-46D1-B4A1-17B808A92341Q43961908-A88FDCE3-7A66-49DD-A9A8-F2E864216BFCQ44123275-1BEA3B6B-89BF-4C3D-ABD3-086866C30E47Q44348910-6D88FCF7-E865-40A3-A2B6-DBB5A3F34A7AQ44455839-CBD713AB-A1BD-45FB-A785-CA1A5C4BFCCEQ44566398-EFC19E55-BB83-4174-9C10-26801E956E32Q44763557-8D802C36-45E7-4C6E-A60F-59584751623BQ45151284-ABA0C10F-6DC6-4C7C-8B08-EECC4D3CB19AQ45941900-C7FEABF4-06DF-4CEC-81ED-6C33AB60FF0EQ46790700-38FF6A93-1821-4AA0-B8B1-D86B9AEC32F9Q46961858-ED48F0ED-7E0C-4150-B519-4C294213CD71Q47567358-2EB961AB-DB66-47EA-B8FC-6C26719DE893Q47573171-7FA75AAE-1C12-403C-B85F-6FE1C20063A5Q47738550-D126BDEC-AA75-4D69-A921-B9C550BC47FBQ47893052-1FE63327-BACA-41ED-A996-C3EFEF4A67D8Q47932285-37A72D0B-7817-4316-B4CE-4DDB5184A93BQ48095462-51105381-72F5-40B1-9743-DD36EF3376B6Q48122412-9C815EB1-15FA-486A-9AEE-390A6D0B8EC7Q48180633-4CCE6CE3-3C4F-47D0-9153-18282B023800Q48280395-3AD64346-F250-4FED-BE96-10089EE2B3F3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pietro Giusti
@ast
Pietro Giusti
@en
Pietro Giusti
@es
Pietro Giusti
@nl
type
label
Pietro Giusti
@ast
Pietro Giusti
@en
Pietro Giusti
@es
Pietro Giusti
@nl
altLabel
Pietro GIUSTi
@en
prefLabel
Pietro Giusti
@ast
Pietro Giusti
@en
Pietro Giusti
@es
Pietro Giusti
@nl
P106
P1153
7102529542
P31
P496
0000-0001-9352-4046